LINC01194: A Potential Drug Target and Biomarker (G404663)

Target Name: LINC01194

NCBI ID: G404663

LINC01194

LINC01194: A Potential Drug Target and Biomarker

Introduction

LINC01194 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its unique 3'-end overlap pattern and conserved sequence features. LINC01194 plays an important role in gene expression regulation, RNA binding protein (RBP) function, RNA splicing, and miRNA regulation. In addition, LINC01194 may also serve as a drug target and biomarker. This article will review the structure, function, mechanism of action of LINC01194 and its application in drug research and development.

Structure

LINC01194 consists of 79 nucleotides, and its longest monomer is 19 nucleotides. The 3'-end of LINC01194 consists of a special domain consisting of a conserved nucleotide sequence that is bound by multiple antisense RNA binding proteins (RBPs).

Function

LINC01194 plays an important role in the regulation of gene expression. Studies have shown that LINC01194 can regulate the expression levels of multiple genes by binding to RBP. In addition, LINC01194 is also involved in the RNA splicing process. In some studies, LINC01194 can increase the stability of RBP binding after binding to RBP, thereby promoting RNA splicing.

Mechanism

The mechanism of action of LINC01194 mainly involves RBP binding and RNA splicing. First, LINC01194 promotes RNA binding by binding to RBP and providing binding sites for RNA-binding proteins. Secondly, by binding to RBP, LINC01194 can affect the conformation of RBP, thereby affecting the stability of the RNA conjugate. In addition, LINC01194 is also involved in the RNA splicing process. In some studies, LINC01194 can increase the stability of RBP binding after binding to RBP, thereby promoting RNA splicing.

Applications in drug development

LINC01194 has great potential in drug development. Since LINC01194 is expressed in a variety of organisms, it can be used as a screening marker for drug targets. In addition, LINC01194 plays an important role in RNA-binding proteins and RNA splicing processes and therefore can be a target for drug intervention.

in conclusion

LINC01194 is a non-coding RNA with a unique structure and conserved sequence. It plays an important role in the regulation of gene expression, RNA-binding proteins, and RNA splicing processes. In addition, LINC01194 may also serve as a drug target and biomarker. In the future, LINC01194 will play an important role in drug research and development and provide a new theoretical basis for medical research.

Protein Name: Long Intergenic Non-protein Coding RNA 1194

The "LINC01194 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01194 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets